Bioxytran, Inc.
BIXT
$0.04
$0.000.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -522.20K | -282.70K | 35.40K | -1.35M | -752.10K |
| Total Depreciation and Amortization | 2.90K | 4.20K | 2.50K | 1.90K | 2.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 622.80K |
| Total Other Non-Cash Items | 101.70K | -73.80K | -265.30K | 831.80K | -342.00K |
| Change in Net Operating Assets | 180.50K | 310.80K | 146.70K | 352.70K | 340.60K |
| Cash from Operations | -237.00K | -41.50K | -80.70K | -167.30K | -127.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.20K | -1.70K | -15.20K | 0.00 | -12.10K |
| Cash from Investing | -6.20K | -1.70K | -15.20K | 0.00 | -12.10K |
| Total Debt Issued | 20.80K | 41.20K | 94.60K | 166.50K | 110.50K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 425.60K | 13.40K | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 292.20K | -- | -- | -- | -- |
| Cash from Financing | 738.60K | 54.50K | 94.60K | 166.50K | 110.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 495.40K | 11.40K | -1.20K | -800.00 | -29.50K |